Company / Working Capital
LivaNova Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$293.5M
FY2025
5-year range
-$17.8M / $735.1M
FY2021-FY2025
Trend
-60.1%
vs FY2024
Sector context
#92 of 160
Health Care
What the data says
At $294M, LivaNova's working capital ranks #92 of 160 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from -$18M in FY2021 to $735M in FY2024.
Based on SEC 10-K filings.
$294M in FY2025 with a 5-year CAGR of -6.0%.
Declined from $653M to $294M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -20.7%
- 5-Year CAGR
- -6.0%
- 10-Year CAGR
- -
Sector benchmark
#92 of 160 in Health CareTop 57% of 160This company $293.5M Sector average $757.1M
▼
-61.2% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.0%, indicating a declining trend.
- In FY2025, working capital decreased 60.1% year-over-year.
- Ranks #92 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $293.5M | -60.1% |
| FY2024 | $735.1M | +12.5% |
| FY2023 | $653.2M | +10.9% |
| FY2022 | $588.7M | +3409.6% |
| FY2021 | -$17.8M | -104.5% |
| FY2020 | $399.0M | +981.6% |
| FY2019 | $36.9M | +0.9% |
| FY2018 | $36.6M | -92.1% |
| FY2017 | $463.8M | +0.2% |
| FY2016 | $462.8M | +121.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026